A detailed history of Bank Plus Trust Department transactions in Novo Nordisk A S stock. As of the latest transaction made, Bank Plus Trust Department holds 270 shares of NVO stock, worth $19,367. This represents 0.01% of its overall portfolio holdings.

Number of Shares
270
Holding current value
$19,367
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 04, 2025

BUY
$85.0 - $120.04 $22,950 - $32,410
270 New
270 $23.2 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $162B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Bank Plus Trust Department Portfolio

Follow Bank Plus Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Plus Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Bank Plus Trust Department with notifications on news.